Emeryville, CA – According to filings with the U.S. Securities and Exchange Commission, Metagenomi Technologies is raising $40,200,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Brian Thomas played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Metagenomi Technologies

Founded in 2018 by lead metagenomics researchers at UC Berkeley, Brian C. Thomas and Jillian Banfield, Metagenomi is committed to changing the landscape of cell and gene therapies. By using metagenomics to unlock 4 billion years of microbial evolution, Metagenomi is rapidly identifying and characterizing novel nucleases with unique gene editing capabilities. Metagenomi is using this expanded gene editing toolbox to develop game-changing in vivo and ex vivo therapeutics.

To learn more about Metagenomi Technologies, visit http://www.metagenomi.co/

Contact:
Brian Thomas, Chief Executive Officer
510-878-6868
https://www.linkedin.com/in/b-c-thomas/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved